L'Orรฉal's $4.66 billion acquisition of Kering's beauty division, including the House of Creed, signals a major consolidation trend in the luxury cosmetics market. This deal could spark further M&A activity, creating opportunities for other established beauty companies and niche brands that may become acquisition targets.
10์ 21 ๊ฒ์
L'Orรฉal's ยฃ4.66 billion acquisition proves major players have massive war chests ready for strategic deals. This could trigger a domino effect of mega-acquisitions across the luxury beauty space.
Niche beauty brands with strong consumer loyalty are becoming irresistible to global conglomerates. Companies in this group could command premium valuations if they become acquisition targets.
Industry experts predict this landmark deal will pressure other beauty giants to make similar moves. Early positioning in quality consolidation plays could capture significant upside as M&A activity accelerates.
L'Orรฉal's massive ยฃ4.66 billion acquisition of Kering's beauty division signals a new wave of consolidation in luxury cosmetics. Major conglomerates are actively purchasing high-growth, niche brands to expand market share and capture new consumer segments, creating a compelling investment theme around beauty buyouts.
This group includes established beauty giants positioned as consolidators, innovative brands that could become attractive acquisition targets, and key retailers benefiting from industry growth. The M&A activity could support valuations across the sector as buyout potential increases for quality brands.
These companies were handpicked based on their strategic positioning in the beauty consolidation trend. They include the key players from the headline L'Orรฉal-Kering deal, other major conglomerates with M&A capabilities, and potential targets with strong brand equity that could attract billion-dollar bids.
Aggregate market capitalisation and investor takeaways for the 'Beauty's Billion-Dollar Buyouts' basket.
EL: $36.94B
COTY: $3.61B
ULTA: $23.48B
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
ESTEE LAUDER COMPANIES INC
EL
ํ์ฌ๊ฐ
$109.40
Estรฉe Lauder Companies, a major beauty conglomerate with brands like MAC and Clinique, is well-positioned to participate in the consolidation wave as ...
Estรฉe Lauder Companies, a major beauty conglomerate with brands like MAC and Clinique, is well-positioned to participate in the consolidation wave as both an acquirer and potential target.
COTY INC
COTY
ํ์ฌ๊ฐ
$3.36
Coty, owner of luxury fragrance brands like Calvin Klein and Hugo Boss, represents a mid-tier player that could benefit from increased M&A activity in...
Coty, owner of luxury fragrance brands like Calvin Klein and Hugo Boss, represents a mid-tier player that could benefit from increased M&A activity in the beauty sector.
ULTA BEAUTY INC
ULTA
ํ์ฌ๊ฐ
$618.00
Ulta Beauty, America's largest beauty retailer, stands to benefit from increased brand consolidation and the resulting marketing investments from majo...
Ulta Beauty, America's largest beauty retailer, stands to benefit from increased brand consolidation and the resulting marketing investments from major beauty conglomerates.
Join Nemo FREE today and unlock every stock
60์ด๋ฉด ์ถฉ๋ถํฉ๋๋ค.
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
์ธ์ฌ์ดํธ ์ ์ฒด ์ฝ๊ธฐ
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+102.83%
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 102.83% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 11๊ฐ ์ค 8๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
